MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognitive impairment in patients with Parkinson’s syndrome

SH. Rakhimova, I. Usmonaliev, Y. Musaeva (Tashkent, Uzbekistan)

Meeting: 2019 International Congress

Abstract Number: 1043

Keywords: Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: Study the principle of cognitive impairment in Parkinson’s syndrome (brain cerebral circulation disorder, backdrop of atherosclerosis).

Background: Parkinsonism-neurologic syndrome is a disorderly degenerative disease of the nervous system, characterized by akinesia, rigidity, tremor in calmness and postural insufficiency. One of the pressing problems in the world of medicine. In the last 20 years, cerebral hemorrhages and atherosclerosis have been associated with Parkinson’s syndrome. Loss of cerebral blood vessels is one of the main causes of Parkinsonism development. The first symptoms of the disease appear in the 50’s and 60’s of the patient’s life.

Method: Neurology Department presented 24 patients with cognitive impairment in Parkinson’s syndrome. 46% of them (11) had cerebral (75% male, 25% female) atherosclerosis, 37% (9) hypertension (40% in men, 60% in women), 17% (4) (75% in men and 25% in women). Both patients have an average age of 58 and 10 for men and 14 males. Cognitive functions were evaluated in a total 30-point scale in the MMSE scale. The scale was inspected at 9 stages. 23 points (19-27) for women in the MMSE scale; in men with 25 points (18-28).

Results: Cognitive disorders are mainly: recall – 85% (20) (80% of men), (100% of women); attention  and calculation: 57% (14) (40% men), (100% women); repetition-100% (24)  (100% of men), (100% for women);complex commands-100% (24) (100% of men), (100% of women); orientation to time – 17% (4) (50% men, 50% women); orientation to place – 0%; registration – 0%; language- 0% in patients.

Conclusion: Patients with parkinsonism need to conduct a comprehensive neuropsychological study for the early detection of cognitive impairments and groups of risk with the inevitable progression of cognitive impairments and the further formation of dementia for the timely start of their correction.

References: 1.Association between mild parkinsonian signs and mild cognitive impairment in a community-ED Louis, N Schupf, J Manly…-Neurology,2005-AAN Enterprises 2.The distinct cognitive syndromes of Parkinson’s disease: 5 years follow-up of the CamPaIGN cohort-CH Williams-Gray,JR Evans,A Goris, T Foltynie-Brain,2009 3.Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease-AA Kehagia, RA Barker, TW Robbins -The Lancet Neurology-2010

To cite this abstract in AMA style:

SH. Rakhimova, I. Usmonaliev, Y. Musaeva. Cognitive impairment in patients with Parkinson’s syndrome [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/cognitive-impairment-in-patients-with-parkinsons-syndrome/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognitive-impairment-in-patients-with-parkinsons-syndrome/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley